Dietary Treatment of Endometriosis-related Irritable Bowel Syndrome
1 other identifier
interventional
22
1 country
1
Brief Summary
Many patients with endometriosis experience extra genital and abdominal symptoms as a major part of their problem. This includes gastrointestinal dysfunction with pain, urinary symptoms compatible with interstitial cystitis and gastrointestinal symptoms resembling the irritable bowel syndrome (IBS). Such problems may be secondary to changes in autonomous neuronal structure and function elicited by the endometriotic elements, which may cause a "visceral syndrome" with the above mentioned symptoms. The investigators hypothesize that dietary treatment will improve the experience of gastrointestinal symptoms, pain and quality of life in patients with endometriosis-related irritable bowel syndrome. The aim of this first randomized, placebo controlled pilot study investigating patients with both endometriosis and IBS, is to test the application of a low FODMAP diet and a placebo diet for endometriosis-related IBS-like symptoms in order to stablish a platform for a randomized controlled study. Thus, the primary aim of this pilot study is to investigate the applicability of a placebo diet in patients with endometriosis and to investigate the compliance in both intervention group and control group. In addition, the aim is to investigate whether the participants find the diet manageable and whether they are able to identify the placebo diet.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 15, 2016
CompletedFirst Posted
Study publicly available on registry
October 5, 2016
CompletedStudy Start
First participant enrolled
July 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2018
CompletedMay 17, 2018
October 1, 2017
5 months
September 15, 2016
May 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Compliance to the diet measured by a self-administered questionnaire with a percentage scale for every meal consumed
four weeks
How manageable the participants experience the diet, measured by semi-quantitative questionnaire designed by the study group
four weeks
Identification of intervention group measured by the question: "What group do you think you were assigned to?"
four weeks
Secondary Outcomes (6)
Gastrointestinal symptoms measured by the questionnaire: The Gastrointestinal symptom rating scale (GSRS) irritable bowel syndrome (IBS) version
four weeks
IBS related quality of life measured by the questionnaire: Irritable bowel syndrome - Quality of Life
four weeks
Endometriosis related quality of life measured by the questionnaire: The Endometriosis Health Profile (EHP-30)
four weeks
Intake of nutrients calculated in by: The Monash University Comprehensive Food Frequency Questionnaire (CNAQ) based on the participants self-reported 7-days food registration
four weeks
Intermenstrual pain measured by VAS scale
four weeks
- +1 more secondary outcomes
Study Arms (2)
Low FODMAP diet
EXPERIMENTALThis group will follow a exclusion diet called low FODMAP diet, which is a diet with restriction of fermentable carbohydrates. The patients will be guided on how to avoid some foods and how to include others. The patients will follow the diet for four weeks.
Control diet
PLACEBO COMPARATORThis group will follow a placebo diet, which is designed to imitate the low FODMAP diet by restricting specific foods. However, it is randomly selected foods that will be excluded in this diet, so that it works only as a control diet. The patients in this group will also be guided how to follow the diet for four weeks.
Interventions
The participants follow the diet in 4 weeks. They have been provided with some foods (bread, pasta, cereal products), but will by the rest themselves. They have been provided with lists of foods to include and foods to avoid. They have also been provided with suggestions to a 4 week meal plan, based in their individual need for energy.
Eligibility Criteria
You may qualify if:
- Signed informed consent
- Age 18-50 years
- Fluid spoken and written Danish
- Diagnosed endometriosis (laparoscopy and/or MR-scan) at least one year ago and sufficient treated regarding medicine and surgery. Participant will be asked to bring a copy of their medical record from the hospital or from www.sundhed.dk to verify the diagnosis.
- Diagnosis of irritable bowel syndrome according to the Rome III criteria. Both previous diagnosis and undiagnosed patients are included, as long as the study group evaluates that the patient meets the Rome III criteria.
You may not qualify if:
- Premature menopause
- Organic bowel disease (Celiac disease, IBD, bowel endometriosis, malignant disease)
- New therapeutic interventions during study period (medical/lifestyle/psychological). Already ongoing treatment is accepted.
- Psychiatric disorder, psychotropic drugs
- Patients, who the dietician accesses are familiar with low FODMAP diet and therefore is able to identify the placebo diet
- Patients with complicated dietary needs, e.g. severe allergies or intolerances (including lactose and fructose intolerance), athletes, any type of vegetarianism or metabolic diseases
- Pregnancy or planned pregnancy during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Aarhus University Hospital
Aarhus, Denmark
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 15, 2016
First Posted
October 5, 2016
Study Start
July 3, 2017
Primary Completion
December 1, 2017
Study Completion
February 1, 2018
Last Updated
May 17, 2018
Record last verified: 2017-10